Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Completed Phase 1 Trials for Belinostat (DB05015)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00348985 | PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas | Treatment |